A chiropractic practice already sees the patients regenerative medicine is built for. Chronic knee pain, degenerative discs, shoulders that never fully recovered, patients who have been managing the same complaint for years with adjustments that help but do not resolve it. The demand is sitting in your existing schedule. The question is what it actually takes to serve it.
Adding regenerative medicine to a chiropractic practice is mostly a hiring decision. Chiropractic scope does not cover injections in most states, so practices bring on an MD or DNP to perform the procedures — often part-time at first. The clinical capability is the part you can buy; the consultation and follow-up process is the part you have to build.
The Clinical Side Is a Hire, Not a Reorganization
The practical answer for most chiropractic practices is straightforward: hire a medical provider to perform the injections. An MD or a DNP working in your practice, on the days you need them, doing the procedures your scope does not cover. Integrated practices have run this way for years, and it is a normal hire rather than an exotic arrangement.
That matters because owners frequently talk themselves out of this at the first hurdle, assuming that because chiropractic scope excludes injections, adding regenerative medicine means restructuring the business. It usually does not. It means adding a provider, the same way you would add any other clinician, with the paperwork done correctly.
Many practices start with that provider part-time — a day or two a week — and increase hours as case volume justifies it. That keeps the fixed cost proportional to the demand you have actually proven, which is the right way to open any new service line.
The caveat is structural rather than difficult. Supervision requirements, corporate practice of medicine rules, and permissible ownership arrangements vary by state, and they are worth getting right the first time. Have a healthcare attorney set the structure up front. That is a defined, one-time task — not an ongoing obstacle, and not a reason to abandon the idea.
Which is the real point: the clinical capability is the part you can buy. What you cannot buy off the shelf is the commercial process for selling a five-figure cash-pay treatment, and that is where practices actually stall.
Why the Chiropractic Patient Base Is Genuinely Well-Suited
Most practices adding a new service line have to go find the patients. You largely do not, and that is the real asset here.
Your schedule is full of people with exactly the profile: chronic musculoskeletal complaints, years of conservative management, an active preference for avoiding surgery, and an existing relationship with a provider they trust. That last one matters more than it sounds. The hardest part of selling a $15,000 to $25,000 cash-pay treatment is trust, and you already have it.
You also have longitudinal history most clinics never get. You know which patients have plateaued, which keep returning with the same complaint, and which have mentioned that surgery was raised. That is a candidacy list no advertising budget can buy.
The constraint is not demand. It is that serving this demand requires a different clinical structure and a completely different commercial process, which is where most practices underestimate the work.
The Financial Model Is Different From Your Current One
Chiropractic revenue is typically many small transactions, often insurance-influenced, with a visit price the patient barely thinks about. Regenerative medicine is a small number of large cash-pay decisions.
Those are different businesses wearing the same white coat. A practice doing well on volume of $60 visits has built systems for throughput: quick intake, efficient rooms, high patient counts per day. None of those systems help when the task is guiding one patient through a $20,000 decision that will take weeks and involve their spouse.
Practically, that means the sales process is the thing you have to build, not the clinical capability. Practices that add a medical provider and assume the treatments will sell themselves discover that a full waiting room converts at a disappointing rate, because nobody in the building has ever run a five-figure consultation. The framework is in our stem cell clinic sales guide.
Which Patients to Start With
Do not open the offer to your entire list. Start narrow, for both clinical and commercial reasons.
The best starting cohort is usually knees and lower back — the highest-volume complaints in most chiropractic practices, the ones where patients have typically exhausted conservative care, and the ones where the alternative (surgery) is concrete enough that patients can weigh the comparison themselves.
Narrowing also makes your marketing coherent. A practice that says it treats everything regeneratively sounds promotional. A practice known locally for knees builds a referral reputation quickly, which is the durable version of this business. That positioning argument is covered in how to differentiate a stem cell clinic.
What This Costs to Stand Up
The cost profile surprises people because the largest lines are not equipment. Diagnostic ultrasound for guidance is a real but manageable purchase. The bigger items are the medical provider's compensation, biologics acquisition, appropriate facility and procedure-room requirements, insurance and coverage changes, and the training time before anyone is efficient.
Then there is the cost most practices omit entirely: the commercial buildout. Someone has to run consultations, follow up over a weeks-long decision cycle, and manage a pipeline that behaves nothing like a chiropractic schedule. That is either a new hire or a substantial retraining of existing staff, and it is not optional. We break the full picture down in what it costs to add a regenerative medicine service line.
The Marketing Shift Nobody Warns You About
Advertising a chiropractic practice and advertising regenerative medicine are governed by different rules and different patient psychology.
Outcome claims, before-and-after imagery, and anything resembling a cure promise will get ads rejected and can attract regulatory attention. This trips up practices whose existing marketing has been comparatively unconstrained. The specifics are in why stem cell ads get rejected.
The patient psychology differs too. A new chiropractic patient decides in minutes for a small amount of money. A regenerative patient takes weeks, involves a spouse, researches heavily, and needs education before they will even have the price conversation. Marketing built for the first behavior produces leads that never convert under the second.
The Sequence That Works
Practices that add this successfully tend to follow the same order.
Settle the legal and staffing structure first, with counsel. Then pick a narrow starting indication. Then build the consultation and follow-up process before you generate a single new lead, because your first candidates should come from your existing patient base — they are warmer, cheaper, and more forgiving while the process is rough. Only once you are converting your own patients reliably should you spend on outside acquisition.
The common failure is running that sequence backwards: buying ads before anyone can close, then concluding regenerative medicine does not work in your market. What did not work was selling a five-figure treatment with no sales process.
Our guide to introducing regenerative medicine to your existing patients covers that first phase in detail.
Frequently Asked Questions
Can a chiropractor perform regenerative injections?
In most states, no — injections fall outside chiropractic scope. That is why the standard approach is simply hiring an MD or DNP to perform them in your practice. Scope and supervision rules vary by state, so confirm the structure with your board and a healthcare attorney rather than copying what a colleague in another state does.
Do I need to hire a physician full time?
No. Most practices start with an MD or DNP working one or two days a week and add hours as case volume justifies it. That keeps the fixed cost tied to demand you have actually proven. What matters more than hours is that the arrangement is structured correctly for your state.
Will my existing patients actually pay $20,000?
Some will, and they are usually not the ones you predict. The determining factors are how much the problem limits their life and whether they have been told surgery is next, not apparent wealth. This is why a structured consultation matters — guessing at who can afford it means disqualifying patients who would have proceeded.
How long before it contributes meaningful revenue?
Expect several months. The clinical setup is the fast part; building a consultation process, training whoever runs it, and working through a decision cycle that takes weeks per patient is what sets the timeline.
What is the most common reason this fails?
No sales infrastructure. Practices add the clinical capability, generate interest, and then lose patients in an unstructured consultation and nonexistent follow-up. The treatment side is rarely the constraint.
Thinking about adding regenerative medicine? Book a free strategy call.